Michał Oręziak

Michał Oręziak

Auto-generated profile, based on publicly available information

Michał Oręziak

Military University of Technology in Warsaw

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AHAbdulla Zahi Othman Hourani
Abdulla Zahi Othman Hourani
ASArman David Sürmeli
Arman David Sürmeli
SDSai Keertana Devarapalli
Sai Keertana Devarapalli
MOMichał Oręziak
Michał Oręziak
Background Congestive heart failure (CHF) is a chronic syndrome with high mortality rates, necessitating risk stratification tools. Existing models are complex and may not incorporate crucial inflammatory and nutritional biomarkers. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score and modified HALP (mHALP) score, which reflect nutritional status and systemic inflammation, emerged as potential prognostic tools. This study aimed to evaluate the predictive performance of HALP and mHALP scores for 90-day mortality in CHF patients. Methods This retrospective study utilized the MIMIC-IV database for 1000 adult CHF patients. HALP was calculated as [Hemoglobin (g/L) * Albumin (g/L) * Lymphocytes (/L)] / Platelets (/L), and mHALP by multiplying these components. The primary outcome was 90-day all-cause mortality. Univariate and multivariate logistic regression analyses were performed, and models were assessed using Receiver Operating Characteristic (ROC) analysis and Youden’s Index. Results Non-survivors (13.2%) had significantly lower median HALP (19.69 vs. 27.18) and mHALP (583,920.75 vs. 1,151,898.94) scores compared to survivors. In univariate analysis, HALP had an AUC of 0.63 and an OR of 0.25 for 90-day mortality, while mHALP showed a higher AUC of 0.68 and an OR of 0.22. After confounder adjusting, both log-transformed HALP (OR: 0.44) and mHALP (OR: 0.57) remained significant predictors of mortality. mHALP demonstrated better overall predictive performance. Conclusion Both HALP and mHALP scores are significantly associated with 90-day mortality in CHF patients, with mHALP exhibiting superior prediction. Easily calculable scores, derived from routine laboratory tests, offer a cost-effective, early risk stratification in CHF, potentially aiding in tailoring interventions.